cobimetinib plus vemurafenib for advanced braf-mutated melanoma
Published 9 years ago • 860 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
2:24
biomarker analysis of cobrim: phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
-
6:48
vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma
-
6:36
imspire 150: atezolizumab, cobimetinib and vemurafenib in untreated patients with brafv600 mutat...
-
2:02
trial results of vemurafenib, cobimetinib and ldh as a predictive marker in braf-mutated melanoma
-
7:10
columbus: encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with braf-m...
-
6:58
triplet therapies for advanced metastatic melanoma
-
6:22
vemurafenib in patients with braf600 mutation–positive metastatic melanoma
-
4:49
vemurafenib for high risk melanoma patients
-
7:58
regulatory approvals for vemurafenib/cobimetinib, necitumumab, and elotuzumab
-
2:36
hamid: cobimetinib, zelboraf for previously untreated melanoma
-
3:40
brim8: vemurafenib in high risk melanoma patients
-
0:51
dr. mcarthur discusses subpopulation data from cobrim trial in advanced melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
1:33
dr. paul chapman on braf and mek inhibitor combination for advanced melanoma
-
2:47
overall survival results for encorafenib plus binimetinib in braf-mutant melanoma
-
6:16
dabrafenib plus trametinib for stage iii mutant melanoma
-
0:58
dr. antoni ribas on combining vemurafenib and ipilimumab for metastatic melanoma
-
5:05
dabrafenib plus trametinib preferable to vemurafenib alone in melanoma